Covered recipient · General Payments record
JEFFREY J DANZIS
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$1,523.14
- Reported across 91 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $153.00 | 8 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| GlaxoSmithKline, LLC. | $49.30 | 2 |
| ABBVIE INC. | $22.51 | 1 |
| Merck Sharp & Dohme Corporation | $17.92 | 1 |
| Novo Nordisk AS | $16.68 | 1 |
| Acerta Pharma LLC | $16.11 | 1 |
| Lilly USA, LLC | $15.84 | 1 |
| Exact Sciences Corporation | $14.64 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (8)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $22.51 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103600302 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.11 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105880592 | CMS |
| Exact Sciences Corporation | $14.64 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114626994 | CMS |
| GlaxoSmithKline, LLC. | $29.70 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116522380 | CMS |
| GlaxoSmithKline, LLC. | $19.60 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116584809 | CMS |
| Lilly USA, LLC | $15.84 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135054220 | CMS |
| Merck Sharp & Dohme LLC | $17.92 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141936559 | CMS |
| Novo Nordisk Inc | $16.68 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096892981 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.